Skip to Content

Sonidegib

In the US, Sonidegib (sonidegib systemic) is a member of the drug class hedgehog pathway inhibitors and is used to treat Basal Cell Carcinoma.

US matches:

ATC (Anatomical Therapeutic Chemical Classification)

L01XX48

CAS registry number (Chemical Abstracts Service)

0956697-53-3

Chemical Formula

C26-H26-F3-N3-O3

Molecular Weight

485

Therapeutic Category

Antineoplastic agent

Chemical Name

N-{6-[(2R,6S)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl}-2-methyl-4'-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamide (WHO)

Foreign Names

  • Sonidegibum (Latin)
  • Sonidegib (German)
  • Sonid├ęgib (French)
  • Sonidegib (Spanish)

Generic Names

  • Erismodegib (IS)
  • Erismod├ęgib (IS)
  • Erismodegibum (IS)
  • LDE 225 (IS)
  • UNII-0RLU3VTK5M (IS)

Brand Names

  • Odomzo
    Novartis, United States; Novartis Pharma, Switzerland

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide